CEO: | Jeremy Skillington |
CFO: | Ian O’Connel |
Executive Chairman: | Cathal Friel |
Independent Non-Executive Director: | Luke O’Neill |
Independent Non-Executive Director: | Brendan Buckley |
Independent Non-Executive Director: | Edward Gibson |
Non-Executive Dir: |
Address: | 40 Bank Street, Floor 24, London, United Kingdom, E14 5NR |
Phone: | +44 (0)20 7183 1499 |
Website: | http://www.poolbegpharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BKPG7Z60 |
Currency | UK Pounds |
Share Price | 3.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 12.15p |
52 Week Low | 2.40p |
Volume | 321,314 |
Shares Issued | 697.20m |
Market Cap | £22.66m |
Beta | 0.00 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:36 | 50,000 @ 3.25p |
14:33 | 280 @ 3.25p |
14:10 | 24,735 @ 3.25p |
13:52 | 6,955 @ 3.20p |
13:52 | 1,345 @ 3.20p |
CEO | Jeremy Skillington |
CFO | Ian O’Connel |
You are here: research